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Introduction
Pompe disease is a rare, metabolic, multi-system, lysoso-
mal storage disorder with autosomal recessive inheri-
tance, caused by a deficiency of the glycogen-degrading
lysosomal enzyme, acid alpha-glucosidase (GAA). Great
phenotypic variability has led to the classification of sev-
eral subtypes: infantile, late-infantile, childhood, juvenile,
and adult-onset form, based on the age of onset and
degree of organ involvement. In the most severe cases,
disease onset is in infancy and death results from car-
diac and respiratory failure along with muscle weakness
within the first one or two years of life. In the milder,
late-onset forms, muscle weakness is the primary symp-
tom. Weakness of respiratory muscles is the major
cause of mortality in these cases.
Results
We present the first two cases of Pompe disease in Bul-
garia. The first patient is a 57-year-old female, with
onset of the disease at the age of 54, and a slow progres-
sion of limb-girdle muscle weakness, restrictive-obstruc-
tive type of respiratory weakness, and liver involvement.
The second patient is a 45-year-old male with clinical
onset at the age of 35 with proximal muscle weakness
in the lower limbs and restrictive respiratory weakness.
The activity of acid alpha glucosidase in dried blood
spot samples was markedly reduced and subsequently
the genetic testing proved that both patients carried the
same mutations as double heterozygous for g.-32-
13T>G in intron 1 and c.1655T>C; p.(Leu552Pro) in
exon 12 of the GAA gene. The first mutation is quite
common in Caucasians, while the second one is
described only in Greek patients.
Conclusion
We can speculate that c.1655T>C; p.(Leu552Pro) muta-
tion in exon 12, found in the first two Bulgarian patients
with adult-onset Pompe disease, may be typical for the
Balkan population.
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